PET/CT of prostate may improve biopsy guidance

Researchers have discussed using PET/CT imaging and Ga-68 PSMA, which is a combination of a radioactive material and molecular compound, to accurately detect tumors while guiding a surgeon during biopsy of a prostate cancer patient.

Researchers led by Dr. Wolfgang P. Fendler, from the department of nuclear medicine at Ludwig-Maximilians-Universitat of Munich, evaluated subjects with histopathology, the study of tissue changes due to disease, and also evaluated the maximum standard uptake values using Ga-68 PSMA PET/CT to determine the “boundaries” of the prostate tumor before surgery. Read more.